Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.

Hepatology (Baltimore, Md.) - 1 Jul 2018

Doi Akira, Hikita Hayato, Sakamori Ryotaro, Tahata Yuki, Kai Yugo, Yamada Ryoko, Yakushijin Takayuki, Mita Eiji, Ohkawa Kazuyoshi, Imai Yasuharu, Furuta Kunimaro, Kodama Takahiro, Tatsumi Tomohide, Takehara Tetsuo

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Benzimidazoles
Share to Fluorenes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C

Share to Sofosbuvir

Share to Treatment Failure

Share to Viral Nonstructural Proteins

Source

Identifiers

PMID: 29425404
DOI: 10.1002/hep.29836

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Nonstructural protein 5A/P32 deletion after failure of ledipasvir/sofosbuvir in hepatitis C virus genotype 1b infection.PMID 29425404Read ↗

Sustained virological response with sofosbuvir and ledipasvir for hepatitis C virus genotype 5.Semantic proximity Read ↗

Sofosbuvir, pegylated interferon, and ribavirin for retreatment of hepatitis C virus genotype 1b following sofosbuvir and ledipasvir failure.Semantic proximity Read ↗

Road to elimination of HCV: Clinical challenges in HCV management.Semantic proximity Read ↗

Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.Semantic proximity Read ↗

Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports.Semantic proximity Read ↗

HCV core residues critical for infectivity are also involved in core-NS5A complex formation.Semantic proximity Read ↗

NS5A-P32 Deletion in Hepatitis C Genotype 1b Infection is the Most Refractory Treatment-Mediated Amino Acid Change Exhibiting Resistance to all NS5A Inhibitors.Semantic proximity Read ↗

Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replicationSemantic proximity Read ↗

NS5A resistance leading to failure of 24-week therapy with sofosbuvir/ledipasvir and ribavirin for the treatment of hepatitis C genotype 1a infection in a HIV-1 co-infected patient.Semantic proximity Read ↗

Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus.Semantic proximity Read ↗

Interferon therapy for fulminant hepatitis associated with precore region mutation in hepatitis B virus carrier.Semantic proximity Read ↗

Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.